Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
ERBB2 Activates PTK6 Signaling	3/8	6.439790817968128E-5	0.022549103784049236	0	0	56.5448275862069	545.681866955265	ERBB3;EGF;ERBB2
ERBB2 Regulates Cell Motility	3/9	9.583858907502763E-5	0.022549103784049236	0	0	47.117816091954026	435.97385588719123	ERBB3;EGF;ERBB2
PI3K Events in ERBB2 Signaling	3/10	1.3583797460270624E-4	0.022549103784049236	0	0	40.38423645320197	359.5831695521786	ERBB3;EGF;ERBB2
SHC1 Events in ERBB2 Signaling	3/13	3.161925262111212E-4	0.02664249153138295	0	0	28.263793103448275	227.78241018764626	ERBB3;EGF;ERBB2
GRB7 Events in ERBB2 Signaling	2/3	3.3758556731600857E-4	0.02664249153138295	0	0	187.45142857142858	1498.4289000440385	ERBB3;ERBB2
Interferon Signaling	8/165	3.982893628347605E-4	0.02664249153138295	0	0	4.898352994384352	38.3459323888946	GBP6;GBP7;OAS1;TUBAL3;IFNGR1;STAT2;FANCA;GBP4
Signaling by ERBB2 TMD JMD Mutants	3/14	3.9927487257807097E-4	0.02664249153138295	0	0	25.692789968652036	201.0681894967224	ERBB3;EGF;ERBB2
RAC1 GTPase Cycle	6/91	4.2799183182944497E-4	0.02664249153138295	0	0	6.736016511867905	52.24728190025743	SYDE2;TIAM2;FARP2;PLEKHG1;ARHGEF25;ESYT1
Downregulation of ERBB2 Signaling	3/15	4.95186318936214E-4	0.027400309647803843	0	0	23.55028735632184	179.23126268212923	ERBB3;EGF;ERBB2
Signaling by ERBB2 KD Mutants	3/16	6.046910548088591E-4	0.030113614529481185	0	0	21.73740053050398	161.09137315876276	ERBB3;EGF;ERBB2
Signaling by ERBB2 in Cancer	3/17	7.28524818365016E-4	0.030760645947034378	0	0	20.18349753694581	145.81545321538206	ERBB3;EGF;ERBB2
Interferon Gamma Signaling	5/67	7.412203842658886E-4	0.030760645947034378	0	0	7.66175918979745	55.21992708143833	GBP6;GBP7;OAS1;IFNGR1;GBP4
Choline Catabolism	2/5	0.0011095315783692463	0.040219174553196776	0	0	62.476190476190474	425.07658898587965	DMGDH;BHMT
Cytokine Signaling in Immune System	13/451	0.0011306595255918773	0.040219174553196776	0	0	2.8893111705089654	19.603843861913813	GBP6;GBP7;TUBAL3;IFNGR1;STAT2;FANCA;NLRC5;TNFRSF11A;IL17RA;OAS1;IL2RA;TNFRSF8;GBP4
RHO GTPase Cycle	9/244	0.0012551163670554127	0.0416698633862397	0	0	3.6857142857142855	24.622513755563414	SYDE2;TIAM2;NET1;FARP2;GOLGA3;ANKLE2;PLEKHG1;ARHGEF25;ESYT1
Downregulation of ERBB2 ERBB3 Signaling	2/6	0.001652618564151972	0.048412002643981294	0	0	46.854285714285716	300.12017185515515	ERBB3;ERBB2
Glycosphingolipid Transport	2/6	0.001652618564151972	0.048412002643981294	0	0	46.854285714285716	300.12017185515515	ESYT2;ESYT1
NFE2L2 Regulating Tumorigenic Genes	2/7	0.0022974429298174034	0.06356258772494816	0	0	37.481142857142856	227.73387018796188	EGF;NFE2L2
Potential Therapeutics for SARS	4/60	0.00384443124216052	0.09783255589151846	0	0	6.749380677126342	37.53418072179968	IFNGR1;STAT2;PDCD1;NFE2L2
Signaling by ERBB2	3/30	0.003929018308896324	0.09783255589151846	0	0	10.457215836526181	57.92634249729697	ERBB3;EGF;ERBB2
GRB2 Events in ERBB2 Signaling	2/10	0.004820421659777782	0.10911681757133343	0	0	23.42142857142857	124.95083579349352	EGF;ERBB2
Vitamin D (Calciferol) Metabolism	2/10	0.004820421659777782	0.10911681757133343	0	0	23.42142857142857	124.95083579349352	CUBN;CYP27B1
Signaling by Rho GTPases	10/359	0.005283730599451999	0.11440425384900414	0	0	2.754491017964072	14.442134873060423	SYDE2;TIAM2;NET1;FARP2;GOLGA3;ANKLE2;PLEKHG1;TUBAL3;ARHGEF25;ESYT1
Metabolism	23/1221	0.005537626882734376	0.11490575781673831	0	0	1.895556446892006	9.849669995169313	DMGDH;IPPK;CUBN;SDS;OSBPL3;CSNK2A2;OMD;ACAD9;ACSF3;DHODH;TIAM2;HELZ2;CYP27B1;NEU4;BHMT;EPRS1;NNT;LARS1;B4GALNT1;UGT3A1;D2HGDH;PRODH;COX10
Signaling by Rho GTPases, Miro GTPases and RHOBTB3	10/368	0.006258309464536663	0.11885498204369205	0	0	2.6837386679155655	13.616874515128922	SYDE2;TIAM2;NET1;FARP2;GOLGA3;ANKLE2;PLEKHG1;TUBAL3;ARHGEF25;ESYT1
L1CAM Interactions	4/69	0.006329484598243211	0.11885498204369205	0	0	5.811649622054246	29.421688152163647	TUBAL3;SCN9A;CSNK2A2;SPTB
Sensory Perception	8/257	0.006443944809597762	0.11885498204369205	0	0	3.071029680853592	15.49216048428975	OR7G1;OR10A7;OR6C70;MYO1C;SCN9A;OR6C68;TAS1R2;CNGB1
Signaling by ERBB2 ECD Mutants	2/12	0.006971515881637711	0.12399338960912785	0	0	18.73485714285714	93.03585032958127	EGF;ERBB2
Signaling by Non-Receptor Tyrosine Kinases	3/39	0.008246009090997077	0.1368837509105515	0	0	7.83860153256705	37.609813504017154	ERBB3;EGF;ERBB2
Signaling by PTK6	3/39	0.008246009090997077	0.1368837509105515	0	0	7.83860153256705	37.609813504017154	ERBB3;EGF;ERBB2
Immune System	22/1214	0.010235594201130288	0.1644298681342866	0	0	1.8112253734574584	8.298824569457588	GBP6;GBP7;TMEM63A;PTPRN2;TUBAL3;IFNGR1;STAT2;FANCA;NLRC5;KLHL22;TNFAIP3;TNFRSF11A;PJA2;IL17RA;MYO1C;OAS1;GNLY;IL2RA;TNFRSF8;PDCD1;CD33;GBP4
Olfactory Signaling Pathway	5/136	0.015369286735004827	0.23918452481351263	0	0	3.6108645481981183	15.076746525862045	OR7G1;OR10A7;OR6C70;OR6C68;CNGB1
Metabolism of Steroids	4/92	0.016951372707337584	0.255811624492549	0	0	4.286652653704677	17.478425233785067	HELZ2;CUBN;CYP27B1;OSBPL3
Cytosolic tRNA Aminoacylation	2/20	0.01897947337465255	0.27640838056721856	0	0	10.403174603174604	41.24231660620099	EPRS1;LARS1
Vitamins	1/2	0.021237541472873295	0.27640838056721856	0	0	93.19318181818181	358.97872347789695	CYP27B1
Metabolism of Amino Acids and Derivatives	6/202	0.021446139746784346	0.27640838056721856	0	0	2.901360544217687	11.147638280902493	DMGDH;BHMT;SDS;EPRS1;LARS1;PRODH
Constitutive Signaling by Aberrant PI3K in Cancer	3/56	0.021932448754678306	0.27640838056721856	0	0	5.318802862719584	20.316699670989077	ERBB3;EGF;ERBB2
Negative Regulators of DDX58 IFIH1 Signaling	2/22	0.022756513259550123	0.27640838056721856	0	0	9.361714285714285	35.4144652708887	NLRC5;TNFAIP3
Sensory Perception of Sweet, Bitter, and Umami (Glutamate) Taste	2/22	0.022756513259550123	0.27640838056721856	0	0	9.361714285714285	35.4144652708887	SCN9A;TAS1R2
Sialic Acid Metabolism	2/22	0.022756513259550123	0.27640838056721856	0	0	9.361714285714285	35.4144652708887	NEU4;ST8SIA1
Interaction Between L1 and Ankyrins	2/22	0.022756513259550123	0.27640838056721856	0	0	9.361714285714285	35.4144652708887	SCN9A;SPTB
RAF MAP Kinase Cascade	5/152	0.02361718207942628	0.2800323017989116	0	0	3.2146812213257396	12.041491125083827	ERBB3;EGF;IL2RA;ERBB2;SPTB
Organelle Biogenesis and Maintenance	5/154	0.024814941504322403	0.28739164811982687	0	0	3.1711409395973154	11.721517832951399	HELZ2;BBS2;DYNC2I1;TUBAL3;CNGB1
MAPK1 MAPK3 Signaling	5/155	0.02542820998907897	0.2878011039673029	0	0	3.149806201550388	11.565761081271157	ERBB3;EGF;IL2RA;ERBB2;SPTB
Cellular Response to Chemical Stress	4/106	0.026900112820447065	0.2918165716955228	0	0	3.6951150402357475	13.360149572101156	HELZ2;EGF;CSNK2A2;NFE2L2
Disease	18/1030	0.026979465743753456	0.2918165716955228	0	0	1.7217167574017451	6.220010369985146	CUBN;TUBAL3;IFNGR1;EGF;STAT2;CSNK2A2;OMD;POMT1;IL17RA;CYP27B1;MYO1C;ERBB3;CHMP1A;ERBB2;THSD7A;TOPBP1;PDCD1;NFE2L2
B-WICH Complex Positively Regulates rRNA Expression	2/26	0.03114120660526569	0.2918165716955228	0	0	7.7995238095238095	27.058290240290994	MYO1C;TAF1B
Cilium Assembly	4/111	0.03114531143101802	0.2918165716955228	0	0	3.521365674463832	12.215939944250401	BBS2;DYNC2I1;TUBAL3;CNGB1
Diseases of Metabolism	5/164	0.03138706283238973	0.2918165716955228	0	0	2.9698698259470526	10.27978708435339	CUBN;CYP27B1;OMD;POMT1;THSD7A
NFE2L2 Regulates Pentose Phosphate Pathway Genes	1/3	0.03168755614943728	0.2918165716955228	0	0	46.59375	160.83376117050025	NFE2L2
NFE2L2 Regulating ER-stress Associated Genes	1/3	0.03168755614943728	0.2918165716955228	0	0	46.59375	160.83376117050025	NFE2L2
NFE2L2 Regulating MDR Associated Enzymes	1/3	0.03168755614943728	0.2918165716955228	0	0	46.59375	160.83376117050025	NFE2L2
NFE2L2 Regulating Inflammation Associated Genes	1/3	0.03168755614943728	0.2918165716955228	0	0	46.59375	160.83376117050025	NFE2L2
Threonine Catabolism	1/3	0.03168755614943728	0.2918165716955228	0	0	46.59375	160.83376117050025	SDS
KEAP1-NFE2L2 Pathway	3/65	0.032254292708787706	0.2918165716955228	0	0	4.544215795328142	15.605310263743542	EGF;CSNK2A2;NFE2L2
Sensory Perception of Taste	2/27	0.033400691941053814	0.2918165716955228	0	0	7.487085714285715	25.449942003680057	SCN9A;TAS1R2
Heme Signaling	2/27	0.033400691941053814	0.2918165716955228	0	0	7.487085714285715	25.449942003680057	HELZ2;NFE2L2
Cytoprotection by HMOX1	2/28	0.035722274627746374	0.3067188407692706	0	0	7.198681318681318	23.985868267518924	HELZ2;NFE2L2
PI3K AKT Signaling in Cancer	3/70	0.038905829807890556	0.3109148624554587	0	0	4.203808543489449	13.648131786697313	ERBB3;EGF;ERBB2
Cargo Trafficking to the Periciliary Membrane	2/30	0.04054548982075642	0.3109148624554587	0	0	6.683673469387755	21.423383958991007	BBS2;CNGB1
DNA Replication Initiation	1/4	0.04202662880494237	0.3109148624554587	0	0	31.060606060606062	98.44509510605089	POLE
Regulation of HMOX1 Expression and Activity	1/4	0.04202662880494237	0.3109148624554587	0	0	31.060606060606062	98.44509510605089	NFE2L2
Regulation of NFE2L2 Gene Expression	1/4	0.04202662880494237	0.3109148624554587	0	0	31.060606060606062	98.44509510605089	NFE2L2
HDL Clearance	1/4	0.04202662880494237	0.3109148624554587	0	0	31.060606060606062	98.44509510605089	CUBN
LDL Remodeling	1/4	0.04202662880494237	0.3109148624554587	0	0	31.060606060606062	98.44509510605089	APOF
Uptake of Dietary Cobalamins Into Enterocytes	1/4	0.04202662880494237	0.3109148624554587	0	0	31.060606060606062	98.44509510605089	CUBN
WNT Mediated Activation of DVL	1/4	0.04202662880494237	0.3109148624554587	0	0	31.060606060606062	98.44509510605089	CSNK2A2
MAPK Family Signaling Cascades	5/180	0.043993315639031534	0.3109148624554587	0	0	2.6956810631229238	8.420546310504395	ERBB3;EGF;IL2RA;ERBB2;SPTB
Metabolism of Lipids	9/435	0.04410244676398624	0.3109148624554587	0	0	2.0091800804828974	6.271133266336041	TIAM2;HELZ2;CUBN;CYP27B1;NEU4;OSBPL3;CSNK2A2;B4GALNT1;ACSF3
NRAGE Signals Death Through JNK	2/32	0.04559862590552926	0.3109148624554587	0	0	6.237333333333333	19.260122486050772	TIAM2;NET1
RHOB GTPase Cycle	2/32	0.04559862590552926	0.3109148624554587	0	0	6.237333333333333	19.260122486050772	NET1;ARHGEF25
Translocation of SLC2A4 (GLUT4) to the Plasma Membrane	2/32	0.04559862590552926	0.3109148624554587	0	0	6.237333333333333	19.260122486050772	MYO1C;TUBAL3
PI5P, PP2A and IER3 Regulate PI3K AKT Signaling	3/75	0.04619839527897322	0.3109148624554587	0	0	3.9106800766283527	12.024599050025815	ERBB3;EGF;ERBB2
tRNA Aminoacylation	2/33	0.048207704612054626	0.3109148624554587	0	0	6.0357603686635946	18.301852436256084	EPRS1;LARS1
HDR Through Homologous Recombination (HRR)	2/33	0.048207704612054626	0.3109148624554587	0	0	6.0357603686635946	18.301852436256084	TOPBP1;POLE
Developmental Biology	14/807	0.05061057853963763	0.3109148624554587	0	0	1.6907139928360888	5.044405244824547	FARP2;MYOCD;TUBAL3;EGF;CSNK2A2;HOXC11;SPTB;HELZ2;EPRS1;LARS1;SCN9A;ERBB2;COL9A2;CDH15
Positive Epigenetic Regulation of rRNA Expression	2/34	0.050869861544032294	0.3109148624554587	0	0	5.846785714285715	17.414561454549812	MYO1C;TAF1B
Glycosphingolipid Metabolism	2/34	0.050869861544032294	0.3109148624554587	0	0	5.846785714285715	17.414561454549812	NEU4;B4GALNT1
Nucleotide Biosynthesis	1/5	0.0522559280408302	0.3109148624554587	0	0	23.29403409090909	68.75471619558719	DHODH
OAS Antiviral Response	1/5	0.0522559280408302	0.3109148624554587	0	0	23.29403409090909	68.75471619558719	OAS1
GLI Proteins Bind Promoters of Hh Responsive Genes to Promote Transcription	1/5	0.0522559280408302	0.3109148624554587	0	0	23.29403409090909	68.75471619558719	GLI1
Interleukin-2 Signaling	1/5	0.0522559280408302	0.3109148624554587	0	0	23.29403409090909	68.75471619558719	IL2RA
Maturation of hRSV A Proteins	1/5	0.0522559280408302	0.3109148624554587	0	0	23.29403409090909	68.75471619558719	CSNK2A2
Negative Regulation of the PI3K AKT Network	3/79	0.0524831433883486	0.3109148624554587	0	0	3.7039473684210527	10.916507919095286	ERBB3;EGF;ERBB2
Expression and Translocation of Olfactory Receptors	4/132	0.05306779780866263	0.3109148624554587	0	0	2.9398482658959537	8.631938318796053	OR7G1;OR10A7;OR6C70;OR6C68
Antiviral Mechanism by IFN-stimulated Genes	3/83	0.059157747318599053	0.32158356844266817	0	0	3.517887931034483	9.946995997357716	OAS1;TUBAL3;FANCA
PKR-mediated Signaling	2/37	0.05916075795139001	0.32158356844266817	0	0	5.34465306122449	15.111989584491747	TUBAL3;FANCA
Transcriptional and Post-Translational Regulation of MITF-M Expression and Activity	2/37	0.05916075795139001	0.32158356844266817	0	0	5.34465306122449	15.111989584491747	EPRS1;LARS1
Signaling by ERBB4	2/38	0.062021302101097214	0.32158356844266817	0	0	5.1958730158730155	14.445968166917842	ERBB3;EGF
Mitochondrial Unfolded Protein Response (UPRmt)	1/6	0.062376611470835945	0.32158356844266817	0	0	18.634090909090908	51.701494394184536	LONP1
RUNX1 and FOXP3 Control the Development of Regulatory T Lymphocytes (Tregs)	1/6	0.062376611470835945	0.32158356844266817	0	0	18.634090909090908	51.701494394184536	IL2RA
Defects in Cobalamin (B12) Metabolism	1/6	0.062376611470835945	0.32158356844266817	0	0	18.634090909090908	51.701494394184536	CUBN
Signaling by Overexpressed Wild-Type EGFR in Cancer	1/6	0.062376611470835945	0.32158356844266817	0	0	18.634090909090908	51.701494394184536	EGF
IFNG Signaling Activates MAPKs	1/6	0.062376611470835945	0.32158356844266817	0	0	18.634090909090908	51.701494394184536	IFNGR1
Synthesis of Pyrophosphates in the Cytosol	1/6	0.062376611470835945	0.32158356844266817	0	0	18.634090909090908	51.701494394184536	IPPK
Inhibition of Signaling by Overexpressed EGFR	1/6	0.062376611470835945	0.32158356844266817	0	0	18.634090909090908	51.701494394184536	EGF
Death Receptor Signaling	3/85	0.06263776333120243	0.32158356844266817	0	0	3.4316652649285113	9.50704061406666	TIAM2;NET1;TNFAIP3
Axon Guidance	7/330	0.06408454905635598	0.32334183088354335	0	0	2.049899836095429	5.6322063708365135	FARP2;TUBAL3;SCN9A;CSNK2A2;ERBB2;COL9A2;SPTB
Nuclear Envelope (NE) Reassembly	2/39	0.06492807849067135	0.32334183088354335	0	0	5.055135135135135	13.823141186775858	ANKLE2;TUBAL3
Semaphorin Interactions	2/39	0.06492807849067135	0.32334183088354335	0	0	5.055135135135135	13.823141186775858	FARP2;ERBB2
Signal Transduction	22/1469	0.06596324232415024	0.32524450175670117	0	0	1.4670263281093252	3.988342315313791	FARP2;ANKLE2;PLEKHG1;TUBAL3;ARHGEF25;EGF;CSNK2A2;TNFAIP3;TAAR2;GLI1;SPTB;SYDE2;TIAM2;NET1;GOLGA3;ERBB3;IL2RA;ERBB2;TAS1R2;RGS12;COL9A2;ESYT1
RHOG GTPase Cycle	2/40	0.06787978688969135	0.3314130771673166	0	0	4.921804511278196	13.239737698407106	ANKLE2;ESYT1
Cell Death Signalling via NRAGE, NRIF and NADE	2/41	0.07087514924789429	0.3317410549075478	0	0	4.795311355311355	12.692399902708816	TIAM2;NET1
Activation of the Phototransduction Cascade	1/7	0.07238982509782181	0.3317410549075478	0	0	15.527462121212121	40.77029466928989	CNGB1
Condensation of Prometaphase Chromosomes	1/7	0.07238982509782181	0.3317410549075478	0	0	15.527462121212121	40.77029466928989	CSNK2A2
EGFR Interacts With Phospholipase C-gamma	1/7	0.07238982509782181	0.3317410549075478	0	0	15.527462121212121	40.77029466928989	EGF
Synthesis of Substrates in N-glycan Biosythesis	2/42	0.0739129094179172	0.3317410549075478	0	0	4.675142857142857	12.17812898904593	NEU4;ST8SIA1
Epigenetic Regulation of Gene Expression	4/149	0.07562091192055509	0.3317410549075478	0	0	2.5924656169025315	6.693804349398315	MYO1C;TAF1B;ZNF778;TET1
NCAM Signaling for Neurite Out-Growth	2/43	0.07699183283408831	0.3317410549075478	0	0	4.560836236933798	11.694239198356255	COL9A2;SPTB
Gene Expression (Transcription)	14/863	0.07841471946799596	0.3317410549075478	0	0	1.5735293054983488	4.005802191821997	GTF3C5;CSNK2A2;TNFRSF10C;TET1;MYO1C;TAF1B;IL2RA;ERBB2;ZNF74;ZNF778;DROSHA;ZNF613;TOPBP1;ZNF169
Plasma Lipoprotein Assembly, Remodeling, and Clearance	2/44	0.08011070617408464	0.3317410549075478	0	0	4.451972789115646	11.238318695003361	CUBN;APOF
RAC2 GTPase Cycle	2/44	0.08011070617408464	0.3317410549075478	0	0	4.451972789115646	11.238318695003361	ANKLE2;ESYT1
ATF6 (ATF6-alpha) Activates Chaperone Genes	1/8	0.08229670322024062	0.3317410549075478	0	0	13.308441558441558	33.23682441396952	ATF6
ATF6 (ATF6-alpha) Activates Chaperones	1/8	0.08229670322024062	0.3317410549075478	0	0	13.308441558441558	33.23682441396952	ATF6
Post-chaperonin Tubulin Folding Pathway	1/8	0.08229670322024062	0.3317410549075478	0	0	13.308441558441558	33.23682441396952	TUBAL3
Constitutive Signaling by Overexpressed ERBB2	1/8	0.08229670322024062	0.3317410549075478	0	0	13.308441558441558	33.23682441396952	ERBB2
Defective B4GALT1 Causes B4GALT1-CDG (CDG-2d)	1/8	0.08229670322024062	0.3317410549075478	0	0	13.308441558441558	33.23682441396952	OMD
Defective CHST6 Causes MCDC1	1/8	0.08229670322024062	0.3317410549075478	0	0	13.308441558441558	33.23682441396952	OMD
Defective ST3GAL3 Causes MCT12 and EIEE15	1/8	0.08229670322024062	0.3317410549075478	0	0	13.308441558441558	33.23682441396952	OMD
Receptor Mediated Mitophagy	1/8	0.08229670322024062	0.3317410549075478	0	0	13.308441558441558	33.23682441396952	CSNK2A2
Respiratory Syncytial Virus (RSV) Genome Replication, Transcription and Translation	1/8	0.08229670322024062	0.3317410549075478	0	0	13.308441558441558	33.23682441396952	CSNK2A2
TFAP2 (AP-2) Family Regulates Transcription of Growth Factors and Their Receptors	1/8	0.08229670322024062	0.3317410549075478	0	0	13.308441558441558	33.23682441396952	ERBB2
Nervous System Development	7/351	0.08273463059135897	0.3317410549075478	0	0	1.9222469220246239	4.790464261428969	FARP2;TUBAL3;SCN9A;CSNK2A2;ERBB2;COL9A2;SPTB
Regulation of TP53 Activity Through Phosphorylation	2/45	0.0832683370751877	0.3317410549075478	0	0	4.3481727574750835	10.808196102234904	CSNK2A2;TOPBP1
G Alpha (12 13) Signalling Events	2/45	0.0832683370751877	0.3317410549075478	0	0	4.3481727574750835	10.808196102234904	TIAM2;NET1
Collagen Degradation	2/46	0.08646355381560349	0.33904606141866567	0	0	4.249090909090909	10.401911778371229	MMP15;COL9A2
Selective Autophagy	2/46	0.08646355381560349	0.33904606141866567	0	0	4.249090909090909	10.401911778371229	TUBAL3;CSNK2A2
PIP3 Activates AKT Signaling	4/157	0.08766350453065404	0.3410658223145759	0	0	2.4557028977294193	5.977793811534677	ERBB3;EGF;CSNK2A2;ERBB2
DDX58 IFIH1-mediated Induction of Interferon-Alpha Beta	2/47	0.08969520502013556	0.3445494704305603	0	0	4.154412698412698	10.017693070626924	NLRC5;TNFAIP3
Heme Biosynthesis	1/9	0.09209836834258726	0.3445494704305603	0	0	11.644176136363637	27.770172985082045	COX10
TP53 Regulates Transcription of Death Receptors and Ligands	1/9	0.09209836834258726	0.3445494704305603	0	0	11.644176136363637	27.770172985082045	TNFRSF10C
Microtubule-dependent Trafficking of Connexons From Golgi to the Plasma Membrane	1/9	0.09209836834258726	0.3445494704305603	0	0	11.644176136363637	27.770172985082045	TUBAL3
Chaperonin-mediated Protein Folding	2/50	0.09959755063913275	0.3445494704305603	0	0	3.894047619047619	8.98207918871354	TUBAL3;CSNK2A2
Protein Folding	2/50	0.09959755063913275	0.3445494704305603	0	0	3.894047619047619	8.98207918871354	TUBAL3;CSNK2A2
TNFR2 Non-Canonical NF-kB Pathway	2/50	0.09959755063913275	0.3445494704305603	0	0	3.894047619047619	8.98207918871354	TNFRSF8;TNFRSF11A
PCNA-Dependent Long Patch Base Excision Repair	1/10	0.10179593133678998	0.3445494704305603	0	0	10.349747474747474	23.646949262930388	POLE
RORA Activates Gene Expression	1/10	0.10179593133678998	0.3445494704305603	0	0	10.349747474747474	23.646949262930388	HELZ2
Defects in Vitamin and Cofactor Metabolism	1/10	0.10179593133678998	0.3445494704305603	0	0	10.349747474747474	23.646949262930388	CUBN
Regulation of NF-kappa B Signaling	1/10	0.10179593133678998	0.3445494704305603	0	0	10.349747474747474	23.646949262930388	NLRC5
SEMA3A-Plexin Repulsion Signaling by Inhibiting Integrin Adhesion	1/10	0.10179593133678998	0.3445494704305603	0	0	10.349747474747474	23.646949262930388	FARP2
SHC1 Events in EGFR Signaling	1/10	0.10179593133678998	0.3445494704305603	0	0	10.349747474747474	23.646949262930388	EGF
Sema4D Induced Cell Migration and Growth-Cone Collapse	1/10	0.10179593133678998	0.3445494704305603	0	0	10.349747474747474	23.646949262930388	ERBB2
Signal Transduction by L1	1/10	0.10179593133678998	0.3445494704305603	0	0	10.349747474747474	23.646949262930388	CSNK2A2
GRB2 Events in EGFR Signaling	1/10	0.10179593133678998	0.3445494704305603	0	0	10.349747474747474	23.646949262930388	EGF
Initiation of Nuclear Envelope (NE) Reformation	1/10	0.10179593133678998	0.3445494704305603	0	0	10.349747474747474	23.646949262930388	ANKLE2
Transport of Connexons to the Plasma Membrane	1/10	0.10179593133678998	0.3445494704305603	0	0	10.349747474747474	23.646949262930388	TUBAL3
Diseases of Glycosylation	3/105	0.10228374959191557	0.3445494704305603	0	0	2.7554090601757943	6.282344971569025	OMD;POMT1;THSD7A
P75 NTR Receptor-Mediated Signalling	2/52	0.10636106697852801	0.3445494704305603	0	0	3.7378285714285715	8.376158658202714	TIAM2;NET1
Biosynthesis of the N-glycan Precursor (Dolichol LLO) and Transfer to a Nascent Protein	2/52	0.10636106697852801	0.3445494704305603	0	0	3.7378285714285715	8.376158658202714	NEU4;ST8SIA1
ECM Proteoglycans	2/52	0.10636106697852801	0.3445494704305603	0	0	3.7378285714285715	8.376158658202714	MUSK;COL9A2
Viral Infection Pathways	8/447	0.10663215221256404	0.3445494704305603	0	0	1.7213947783423866	3.853118769499864	TUBAL3;IFNGR1;STAT2;CSNK2A2;CHMP1A;PDCD1;NFE2L2;IL17RA
Nuclear Events Mediated by NFE2L2	2/53	0.1097882485465484	0.3445494704305603	0	0	3.6643137254901963	8.095208410775315	EGF;NFE2L2
Diseases Associated With O-glycosylation of Proteins	2/53	0.1097882485465484	0.3445494704305603	0	0	3.6643137254901963	8.095208410775315	POMT1;THSD7A
HCMV Infection	2/53	0.1097882485465484	0.3445494704305603	0	0	3.6643137254901963	8.095208410775315	TUBAL3;CHMP1A
Cobalamin (Cbl, Vitamin B12) Transport and Metabolism	1/11	0.11139049144441808	0.3445494704305603	0	0	9.314204545454546	20.44200868991772	CUBN
Constitutive Signaling by EGFRvIII	1/11	0.11139049144441808	0.3445494704305603	0	0	9.314204545454546	20.44200868991772	EGF
Regulation of IFNG Signaling	1/11	0.11139049144441808	0.3445494704305603	0	0	9.314204545454546	20.44200868991772	IFNGR1
Signaling by EGFRvIII in Cancer	1/11	0.11139049144441808	0.3445494704305603	0	0	9.314204545454546	20.44200868991772	EGF
Synthesis of Glycosylphosphatidylinositol (GPI)	1/11	0.11139049144441808	0.3445494704305603	0	0	9.314204545454546	20.44200868991772	PIGM
TNF Receptor Superfamily (TNFSF) Members Mediating Non-Canonical NF-kB Pathway	1/11	0.11139049144441808	0.3445494704305603	0	0	9.314204545454546	20.44200868991772	TNFRSF11A
Keratan Sulfate Degradation	1/11	0.11139049144441808	0.3445494704305603	0	0	9.314204545454546	20.44200868991772	OMD
COPI-mediated Anterograde Transport	2/55	0.11672837289712933	0.3583321543943578	0	0	3.5256064690026956	7.572670027807418	TUBAL3;SPTB
Activation of AMPK Downstream of NMDARs	1/12	0.12088313642219299	0.3583321543943578	0	0	8.46694214876033	17.89006466644295	TUBAL3
BBSome-mediated Cargo-Targeting to Cilium	1/12	0.12088313642219299	0.3583321543943578	0	0	8.46694214876033	17.89006466644295	BBS2
RHO GTPases Activate IQGAPs	1/12	0.12088313642219299	0.3583321543943578	0	0	8.46694214876033	17.89006466644295	TUBAL3
Resolution of AP Sites via the Multiple-Nucleotide Patch Replacement Pathway	1/12	0.12088313642219299	0.3583321543943578	0	0	8.46694214876033	17.89006466644295	POLE
Sema4D in Semaphorin Signaling	1/12	0.12088313642219299	0.3583321543943578	0	0	8.46694214876033	17.89006466644295	ERBB2
GAB1 Signalosome	1/12	0.12088313642219299	0.3583321543943578	0	0	8.46694214876033	17.89006466644295	EGF
HDR Through Homologous Recombination (HRR) or Single Strand Annealing (SSA)	2/57	0.12377627456614466	0.3625916749055296	0	0	3.396987012987013	7.097255600926026	TOPBP1;POLE
Interferon Alpha Beta Signaling	2/57	0.12377627456614466	0.3625916749055296	0	0	3.396987012987013	7.097255600926026	OAS1;STAT2
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants	1/13	0.13027494264650064	0.37501110657778797	0	0	7.760890151515151	15.817533224096312	EGF
Signaling by Ligand-Responsive EGFR Variants in Cancer	1/13	0.13027494264650064	0.37501110657778797	0	0	7.760890151515151	15.817533224096312	EGF
Interleukin Receptor SHC Signaling	1/13	0.13027494264650064	0.37501110657778797	0	0	7.760890151515151	15.817533224096312	IL2RA
Intracellular Signaling by Second Messengers	4/183	0.1325744438181673	0.37892768752888245	0	0	2.0956502082862403	4.234493760730608	ERBB3;EGF;CSNK2A2;ERBB2
M Phase	4/184	0.13446371904761287	0.37892768752888245	0	0	2.083879254977521	4.181222168718362	ANKLE2;TUBAL3;CSNK2A2;NCAPG2
Homology Directed Repair	2/60	0.13453357132944704	0.37892768752888245	0	0	3.220689655172414	6.460515070533914	TOPBP1;POLE
SARS-CoV Infections	5/253	0.134679117856651	0.37892768752888245	0	0	1.893637471867967	3.7964784661564597	IFNGR1;STAT2;PDCD1;NFE2L2;IL17RA
SIRT1 Negatively Regulates rRNA Expression	1/14	0.1395669751853497	0.37980521116013194	0	0	7.163461538461538	14.106364996538513	TAF1B
Formation of the Ureteric Bud	1/14	0.1395669751853497	0.37980521116013194	0	0	7.163461538461538	14.106364996538513	HOXC11
Formation of Tubulin Folding Intermediates by CCT TriC	1/14	0.1395669751853497	0.37980521116013194	0	0	7.163461538461538	14.106364996538513	TUBAL3
Gap-filling DNA Repair Synthesis and Ligation in GG-NER	1/14	0.1395669751853497	0.37980521116013194	0	0	7.163461538461538	14.106364996538513	POLE
Synthesis of Very Long-Chain Fatty acyl-CoAs	1/14	0.1395669751853497	0.37980521116013194	0	0	7.163461538461538	14.106364996538513	ACSF3
VxPx Cargo-Targeting to Cilium	1/14	0.1395669751853497	0.37980521116013194	0	0	7.163461538461538	14.106364996538513	CNGB1
Asparagine N-linked Glycosylation	4/189	0.14407366467605986	0.3849193626241452	0	0	2.026933291673176	3.9270424820146594	NEU4;TUBAL3;ST8SIA1;SPTB
Sphingolipid Metabolism	2/63	0.14549159619870752	0.3849193626241452	0	0	3.0617330210772833	5.901909708964178	NEU4;B4GALNT1
Cardiogenesis	1/15	0.14876028797899496	0.3849193626241452	0	0	6.65137987012987	12.673666073391052	MYOCD
Estrogen-dependent Nuclear Events Downstream of ESR-membrane Signaling	1/15	0.14876028797899496	0.3849193626241452	0	0	6.65137987012987	12.673666073391052	EGF
Glucuronidation	1/15	0.14876028797899496	0.3849193626241452	0	0	6.65137987012987	12.673666073391052	UGT3A1
TNFR1-induced Proapoptotic Signaling	1/15	0.14876028797899496	0.3849193626241452	0	0	6.65137987012987	12.673666073391052	TNFAIP3
Infectious Disease	9/565	0.15133619636598689	0.3849193626241452	0	0	1.5268820657759508	2.8831372763140157	MYO1C;TUBAL3;IFNGR1;STAT2;CSNK2A2;CHMP1A;PDCD1;NFE2L2;IL17RA
Aerobic Respiration and Respiratory Electron Transport	3/126	0.1519643929848893	0.3849193626241452	0	0	2.2820297168488928	4.2995928242132715	NNT;ACAD9;D2HGDH
tRNA Processing	2/65	0.15289689086391425	0.3849193626241452	0	0	2.964172335600907	5.566690452854461	EPRS1;TSEN2
NFE2L2 Regulating Anti-Oxidant Detoxification Enzymes	1/16	0.1578559238512588	0.3849193626241452	0	0	6.207575757575758	11.459635123215191	NFE2L2
NOTCH3 Activation and Transmission of Signal to the Nucleus	1/16	0.1578559238512588	0.3849193626241452	0	0	6.207575757575758	11.459635123215191	EGF
BMAL1 CLOCK,NPAS2 Activates Circadian Gene Expression	1/16	0.1578559238512588	0.3849193626241452	0	0	6.207575757575758	11.459635123215191	HELZ2
Citric Acid Cycle (TCA Cycle)	1/16	0.1578559238512588	0.3849193626241452	0	0	6.207575757575758	11.459635123215191	NNT
Condensation of Prophase Chromosomes	1/16	0.1578559238512588	0.3849193626241452	0	0	6.207575757575758	11.459635123215191	NCAPG2
Recognition of DNA Damage by PCNA-containing Replication Complex	1/16	0.1578559238512588	0.3849193626241452	0	0	6.207575757575758	11.459635123215191	POLE
Sealing of the Nuclear Envelope (NE) by ESCRT-III	1/16	0.1578559238512588	0.3849193626241452	0	0	6.207575757575758	11.459635123215191	TUBAL3
Glycosphingolipid Biosynthesis	1/16	0.1578559238512588	0.3849193626241452	0	0	6.207575757575758	11.459635123215191	B4GALNT1
Sulfur Amino Acid Metabolism	1/16	0.1578559238512588	0.3849193626241452	0	0	6.207575757575758	11.459635123215191	BHMT
Synthesis of PC	1/16	0.1578559238512588	0.3849193626241452	0	0	6.207575757575758	11.459635123215191	CSNK2A2
Impaired BRCA2 Binding to RAD51	1/16	0.1578559238512588	0.3849193626241452	0	0	6.207575757575758	11.459635123215191	TOPBP1
Metabolism of Porphyrins	1/16	0.1578559238512588	0.3849193626241452	0	0	6.207575757575758	11.459635123215191	COX10
Cell Cycle	6/341	0.15845074164246942	0.3849193626241452	0	0	1.6829536527886881	3.1005248891112953	ANKLE2;TUBAL3;CSNK2A2;NCAPG2;TOPBP1;POLE
PD-1 Signaling	1/17	0.1668549147557509	0.38972300638936513	0	0	5.819247159090909	10.420122137277096	PDCD1
Cooperation of Prefoldin and TriC CCT in Actin and Tubulin Folding	1/17	0.1668549147557509	0.38972300638936513	0	0	5.819247159090909	10.420122137277096	TUBAL3
RHOF GTPase Cycle	1/17	0.1668549147557509	0.38972300638936513	0	0	5.819247159090909	10.420122137277096	ESYT1
Signaling by EGFR in Cancer	1/17	0.1668549147557509	0.38972300638936513	0	0	5.819247159090909	10.420122137277096	EGF
Cell Cycle, Mitotic	5/274	0.16986994930696306	0.38972300638936513	0	0	1.7435376502118094	3.0908077923156054	ANKLE2;TUBAL3;CSNK2A2;NCAPG2;POLE
Cellular Responses to Stress	7/426	0.17159939426544124	0.38972300638936513	0	0	1.5707988207216061	2.7686784118242858	HELZ2;TUBAL3;EGF;CSNK2A2;LONP1;ATF6;NFE2L2
Selenoamino Acid Metabolism	2/70	0.17171226453596936	0.38972300638936513	0	0	2.745378151260504	4.837178082456899	EPRS1;LARS1
Presynaptic Phase of Homologous DNA Pairing and Strand Exchange	1/18	0.17575828178606992	0.38972300638936513	0	0	5.476604278074866	9.52187407813681	TOPBP1
Class C 3 (Metabotropic Glutamate Pheromone Receptors)	1/18	0.17575828178606992	0.38972300638936513	0	0	5.476604278074866	9.52187407813681	TAS1R2
RNA Polymerase III Transcription Initiation From Type 1 Promoter	1/18	0.17575828178606992	0.38972300638936513	0	0	5.476604278074866	9.52187407813681	GTF3C5
RNA Polymerase III Transcription Initiation From Type 2 Promoter	1/18	0.17575828178606992	0.38972300638936513	0	0	5.476604278074866	9.52187407813681	GTF3C5
Glycosphingolipid Catabolism	1/18	0.17575828178606992	0.38972300638936513	0	0	5.476604278074866	9.52187407813681	NEU4
TNFR1-induced NF-kappa-B Signaling Pathway	1/18	0.17575828178606992	0.38972300638936513	0	0	5.476604278074866	9.52187407813681	TNFAIP3
MicroRNA (miRNA) Biogenesis	1/18	0.17575828178606992	0.38972300638936513	0	0	5.476604278074866	9.52187407813681	DROSHA
DNA Double-Strand Break Repair	2/72	0.17934304554548897	0.38972300638936513	0	0	2.666612244897959	4.582452749682367	TOPBP1;POLE
Macroautophagy	2/73	0.1831779100391277	0.38972300638936513	0	0	2.6288933601609656	4.462013897680183	TUBAL3;CSNK2A2
Metabolism of Proteins	16/1170	0.18451476211416099	0.38972300638936513	0	0	1.313196335726665	2.2193356973555765	MBD6;TUBAL3;ST8SIA1;CSNK2A2;POMT1;KLHL22;TNFAIP3;SPTB;MRPL21;NEU4;EPRS1;LARS1;LONP1;PIGM;THSD7A;NFE2L2
Myogenesis	1/19	0.18456703524866253	0.38972300638936513	0	0	5.172032828282828	8.739403923450237	CDH15
Aggrephagy	1/19	0.18456703524866253	0.38972300638936513	0	0	5.172032828282828	8.739403923450237	TUBAL3
Amino Acid Transport Across the Plasma Membrane	1/19	0.18456703524866253	0.38972300638936513	0	0	5.172032828282828	8.739403923450237	SLC36A1
EGFR Downregulation	1/19	0.18456703524866253	0.38972300638936513	0	0	5.172032828282828	8.739403923450237	EGF
HDR Through Single Strand Annealing (SSA)	1/19	0.18456703524866253	0.38972300638936513	0	0	5.172032828282828	8.739403923450237	TOPBP1
Membrane Trafficking	6/359	0.1863878848638405	0.38972300638936513	0	0	1.5953481437304309	2.680065827349338	DENND1C;MYO1C;TUBAL3;EGF;AMPH;SPTB
O-linked Glycosylation	2/74	0.18702481640410146	0.38972300638936513	0	0	2.5922222222222224	4.345896750467125	POMT1;THSD7A
Activation of the Pre-Replicative Complex	1/20	0.19328217491654118	0.38972300638936513	0	0	4.899521531100478	8.05287373351929	POLE
Ovarian Tumor Domain Proteases	1/20	0.19328217491654118	0.38972300638936513	0	0	4.899521531100478	8.05287373351929	TNFAIP3
RNA Polymerase I Transcription Termination	1/20	0.19328217491654118	0.38972300638936513	0	0	4.899521531100478	8.05287373351929	TAF1B
RUNX1 Interacts With Co-Factors Whose Precise Effect on RUNX1 Targets Is Not Known	1/20	0.19328217491654118	0.38972300638936513	0	0	4.899521531100478	8.05287373351929	CSNK2A2
Defective Homologous Recombination Repair (HRR) Due to BRCA2 Loss of Function	1/20	0.19328217491654118	0.38972300638936513	0	0	4.899521531100478	8.05287373351929	TOPBP1
Regulation of IFNA IFNB Signaling	1/20	0.19328217491654118	0.38972300638936513	0	0	4.899521531100478	8.05287373351929	STAT2
Diseases of DNA Double-Strand Break Repair	1/20	0.19328217491654118	0.38972300638936513	0	0	4.899521531100478	8.05287373351929	TOPBP1
Homologous DNA Pairing and Strand Exchange	1/20	0.19328217491654118	0.38972300638936513	0	0	4.899521531100478	8.05287373351929	TOPBP1
Inactivation, Recovery and Regulation of the Phototransduction Cascade	1/20	0.19328217491654118	0.38972300638936513	0	0	4.899521531100478	8.05287373351929	CNGB1
TNFs Bind Their Physiological Receptors	1/20	0.19328217491654118	0.38972300638936513	0	0	4.899521531100478	8.05287373351929	TNFRSF8
The Phototransduction Cascade	1/20	0.19328217491654118	0.38972300638936513	0	0	4.899521531100478	8.05287373351929	CNGB1
Metabolic Disorders of Biological Oxidation Enzymes	1/20	0.19328217491654118	0.38972300638936513	0	0	4.899521531100478	8.05287373351929	CYP27B1
PPARA Activates Gene Expression	2/77	0.19863096381480444	0.38972300638936513	0	0	2.4880761904761903	4.0214940403145265	TIAM2;HELZ2
CDC42 GTPase Cycle	2/77	0.19863096381480444	0.38972300638936513	0	0	2.4880761904761903	4.0214940403145265	PLEKHG1;ARHGEF25
RHOA GTPase Cycle	2/77	0.19863096381480444	0.38972300638936513	0	0	2.4880761904761903	4.0214940403145265	NET1;ARHGEF25
Regulation of Lipid Metabolism by PPARalpha	2/77	0.19863096381480444	0.38972300638936513	0	0	2.4880761904761903	4.0214940403145265	TIAM2;HELZ2
Respiratory Syncytial Virus Infection Pathway	2/77	0.19863096381480444	0.38972300638936513	0	0	2.4880761904761903	4.0214940403145265	STAT2;CSNK2A2
ATF4 Activates Genes in Response to Endoplasmic Reticulum Stress	1/21	0.20190469005714096	0.38972300638936513	0	0	4.654261363636364	7.446629797465017	ATF6
NOD1 2 Signaling Pathway	1/21	0.20190469005714096	0.38972300638936513	0	0	4.654261363636364	7.446629797465017	TNFAIP3
Phase 0 - Rapid Depolarisation	1/21	0.20190469005714096	0.38972300638936513	0	0	4.654261363636364	7.446629797465017	SCN9A
Plasma Lipoprotein Clearance	1/21	0.20190469005714096	0.38972300638936513	0	0	4.654261363636364	7.446629797465017	CUBN
Cooperation of PDCL (PhLP1) and TRiC CCT in G-protein Beta Folding	1/21	0.20190469005714096	0.38972300638936513	0	0	4.654261363636364	7.446629797465017	CSNK2A2
Resolution of Abasic Sites (AP Sites)	1/21	0.20190469005714096	0.38972300638936513	0	0	4.654261363636364	7.446629797465017	POLE
Fanconi Anemia Pathway	1/21	0.20190469005714096	0.38972300638936513	0	0	4.654261363636364	7.446629797465017	FANCA
Gap Junction Assembly	1/21	0.20190469005714096	0.38972300638936513	0	0	4.654261363636364	7.446629797465017	TUBAL3
Interleukin-2 Family Signaling	1/21	0.20190469005714096	0.38972300638936513	0	0	4.654261363636364	7.446629797465017	IL2RA
Interleukin-20 Family Signaling	1/21	0.20190469005714096	0.38972300638936513	0	0	4.654261363636364	7.446629797465017	STAT2
Termination of Translesion DNA Synthesis	1/21	0.20190469005714096	0.38972300638936513	0	0	4.654261363636364	7.446629797465017	POLE
Keratan Sulfate Biosynthesis	1/21	0.20190469005714096	0.38972300638936513	0	0	4.654261363636364	7.446629797465017	OMD
Plasma Lipoprotein Remodeling	1/22	0.21043555952782986	0.39846733325041545	0	0	4.432359307359308	6.908167967699566	APOF
RNA Polymerase III Transcription Initiation	1/22	0.21043555952782986	0.39846733325041545	0	0	4.432359307359308	6.908167967699566	GTF3C5
Dual Incision in GG-NER	1/22	0.21043555952782986	0.39846733325041545	0	0	4.432359307359308	6.908167967699566	POLE
Transcriptional Activation of Mitochondrial Biogenesis	1/22	0.21043555952782986	0.39846733325041545	0	0	4.432359307359308	6.908167967699566	HELZ2
Transcriptional Regulation by the AP-2 (TFAP2) Family of Transcription Factors	1/22	0.21043555952782986	0.39846733325041545	0	0	4.432359307359308	6.908167967699566	ERBB2
Autophagy	2/81	0.2142341052399502	0.4012718451744784	0	0	2.361518987341772	3.6383590351143744	TUBAL3;CSNK2A2
PERK Regulates Gene Expression	1/23	0.2188757519002842	0.4012718451744784	0	0	4.230630165289257	6.427389333835664	ATF6
Degradation of GLI1 by the Proteasome	1/23	0.2188757519002842	0.4012718451744784	0	0	4.230630165289257	6.427389333835664	GLI1
Recycling Pathway of L1	1/23	0.2188757519002842	0.4012718451744784	0	0	4.230630165289257	6.427389333835664	TUBAL3
Evasion by RSV of Host Interferon Responses	1/23	0.2188757519002842	0.4012718451744784	0	0	4.230630165289257	6.427389333835664	STAT2
Fatty acyl-CoA Biosynthesis	1/23	0.2188757519002842	0.4012718451744784	0	0	4.230630165289257	6.427389333835664	ACSF3
Synthesis of Bile Acids and Bile Salts	1/23	0.2188757519002842	0.4012718451744784	0	0	4.230630165289257	6.427389333835664	OSBPL3
Translesion Synthesis by Y Family DNA Polymerases Bypasses Lesions on DNA Template	1/23	0.2188757519002842	0.4012718451744784	0	0	4.230630165289257	6.427389333835664	POLE
GPCR Downstream Signalling	6/379	0.2195040537574333	0.4012718451744784	0	0	1.5079253092516816	2.2865946844704093	TIAM2;NET1;ARHGEF25;TAAR2;TAS1R2;RGS12
Regulation of TP53 Activity	2/84	0.22601100320387776	0.4012718451744784	0	0	2.2747038327526132	3.382874925178801	CSNK2A2;TOPBP1
SARS-CoV-2 Activates Modulates Innate and Adaptive Immune Responses	2/84	0.22601100320387776	0.4012718451744784	0	0	2.2747038327526132	3.382874925178801	STAT2;IL17RA
Mitophagy	1/24	0.22722622558072872	0.4012718451744784	0	0	4.046442687747035	5.99605587776655	CSNK2A2
tRNA Modification in the Nucleus and Cytosol	1/24	0.22722622558072872	0.4012718451744784	0	0	4.046442687747035	5.99605587776655	EPRS1
Activation of Gene Expression by SREBF (SREBP)	1/24	0.22722622558072872	0.4012718451744784	0	0	4.046442687747035	5.99605587776655	HELZ2
Assembly and Cell Surface Presentation of NMDA Receptors	1/24	0.22722622558072872	0.4012718451744784	0	0	4.046442687747035	5.99605587776655	TUBAL3
RNA Polymerase III Abortive And Retractive Initiation	1/24	0.22722622558072872	0.4012718451744784	0	0	4.046442687747035	5.99605587776655	GTF3C5
RNA Polymerase III Transcription	1/24	0.22722622558072872	0.4012718451744784	0	0	4.046442687747035	5.99605587776655	GTF3C5
GSK3B and BTRC CUL1-mediated-degradation of NFE2L2	1/24	0.22722622558072872	0.4012718451744784	0	0	4.046442687747035	5.99605587776655	NFE2L2
TAK1-dependent IKK and NF-kappa-B Activation	1/24	0.22722622558072872	0.4012718451744784	0	0	4.046442687747035	5.99605587776655	NLRC5
Clathrin-mediated Endocytosis	2/86	0.23388901650057528	0.4100454146606129	0	0	2.2202721088435373	3.225852362667653	EGF;AMPH
Activation of Matrix Metalloproteinases	1/25	0.2354879289014765	0.4100454146606129	0	0	3.8776041666666665	5.607386417633251	MMP15
Diseases of DNA Repair	1/25	0.2354879289014765	0.4100454146606129	0	0	3.8776041666666665	5.607386417633251	TOPBP1
Keratan Sulfate Keratin Metabolism	1/25	0.2354879289014765	0.4100454146606129	0	0	3.8776041666666665	5.607386417633251	OMD
Vesicle-mediated Transport	6/390	0.2385181911246384	0.4138747706622645	0	0	1.4637244152046784	2.0979704002486477	DENND1C;MYO1C;TUBAL3;EGF;AMPH;SPTB
Aspirin ADME	1/26	0.2436618002355303	0.4169882354546188	0	0	3.722272727272727	5.255752608756961	UGT3A1
Carboxyterminal Post-Translational Modifications of Tubulin	1/26	0.2436618002355303	0.4169882354546188	0	0	3.722272727272727	5.255752608756961	TUBAL3
RHOD GTPase Cycle	1/26	0.2436618002355303	0.4169882354546188	0	0	3.722272727272727	5.255752608756961	ESYT1
Interleukin-3, Interleukin-5 and GM-CSF Signaling	1/26	0.2436618002355303	0.4169882354546188	0	0	3.722272727272727	5.255752608756961	IL2RA
ER to Golgi Anterograde Transport	2/89	0.24573517850726603	0.41766593480074565	0	0	2.1433169129720855	3.0081470728165876	TUBAL3;SPTB
MITF-M-regulated Melanocyte Development	2/89	0.24573517850726603	0.41766593480074565	0	0	2.1433169129720855	3.0081470728165876	EPRS1;LARS1
DNA Repair	3/162	0.24980480360071897	0.41930062370000687	0	0	1.7614400346996313	2.4432502317538054	FANCA;TOPBP1;POLE
RNA Polymerase I Transcription Initiation	1/27	0.25174876804478324	0.41930062370000687	0	0	3.57888986013986	4.936447392487748	TAF1B
RND2 GTPase Cycle	1/27	0.25174876804478324	0.41930062370000687	0	0	3.57888986013986	4.936447392487748	GOLGA3
Regulation of TNFR1 Signaling	1/27	0.25174876804478324	0.41930062370000687	0	0	3.57888986013986	4.936447392487748	TNFAIP3
Gap Junction Trafficking	1/27	0.25174876804478324	0.41930062370000687	0	0	3.57888986013986	4.936447392487748	TUBAL3
TP53 Regulates Transcription of Cell Death Genes	1/27	0.25174876804478324	0.41930062370000687	0	0	3.57888986013986	4.936447392487748	TNFRSF10C
Amine Ligand-Binding Receptors	1/28	0.25974975108701165	0.42691543247964286	0	0	3.446127946127946	4.645506624759137	TAAR2
RNA Polymerase I Promoter Escape	1/28	0.25974975108701165	0.42691543247964286	0	0	3.446127946127946	4.645506624759137	TAF1B
DNA Damage Bypass	1/28	0.25974975108701165	0.42691543247964286	0	0	3.446127946127946	4.645506624759137	POLE
Inositol Phosphate Metabolism	1/28	0.25974975108701165	0.42691543247964286	0	0	3.446127946127946	4.645506624759137	IPPK
Post-translational Protein Modification	11/820	0.2607450740226594	0.42714160152396174	0	0	1.2773020388103713	1.716964826355918	NEU4;MBD6;TUBAL3;ST8SIA1;POMT1;KLHL22;TNFAIP3;PIGM;THSD7A;SPTB;NFE2L2
Cellular Responses to Stimuli	7/488	0.2665741238421874	0.4313834884124094	0	0	1.3630182218417513	1.8020503926525575	HELZ2;TUBAL3;EGF;CSNK2A2;LONP1;ATF6;NFE2L2
O-glycosylation of TSR Domain-Containing Proteins	1/29	0.2676656584727601	0.4313834884124094	0	0	3.3228490259740258	4.379570243024528	THSD7A
Defective B3GALTL Causes PpS	1/29	0.2676656584727601	0.4313834884124094	0	0	3.3228490259740258	4.379570243024528	THSD7A
Gap Junction Trafficking and Regulation	1/29	0.2676656584727601	0.4313834884124094	0	0	3.3228490259740258	4.379570243024528	TUBAL3
Kidney Development	1/29	0.2676656584727601	0.4313834884124094	0	0	3.3228490259740258	4.379570243024528	HOXC11
Degradation of the Extracellular Matrix	2/95	0.2694817997228824	0.43290947181288847	0	0	2.0043010752688173	2.6281486527946996	MMP15;COL9A2
Nucleotide-binding Domain, Leucine Rich Repeat Containing Receptor (NLR) Signaling Pathways	1/30	0.27549738972619386	0.4355482542337922	0	0	3.20807210031348	4.135773167434517	TNFAIP3
Collagen Chain Trimerization	1/30	0.27549738972619386	0.4355482542337922	0	0	3.20807210031348	4.135773167434517	COL9A2
Regulation of Cholesterol Biosynthesis by SREBP (SREBF)	1/30	0.27549738972619386	0.4355482542337922	0	0	3.20807210031348	4.135773167434517	HELZ2
Sensory Processing of Sound by Outer Hair Cells of the Cochlea	1/30	0.27549738972619386	0.4355482542337922	0	0	3.20807210031348	4.135773167434517	MYO1C
HSP90 Chaperone Cycle for Steroid Hormone Receptors (SHR) in the Presence of Ligand	1/30	0.27549738972619386	0.4355482542337922	0	0	3.20807210031348	4.135773167434517	TUBAL3
NCAM1 Interactions	1/31	0.28324583491784594	0.4408013305908977	0	0	3.10094696969697	3.911658805304529	COL9A2
COPI-independent Golgi-to-ER Retrograde Traffic	1/31	0.28324583491784594	0.4408013305908977	0	0	3.10094696969697	3.911658805304529	TUBAL3
Diseases Associated With Glycosaminoglycan Metabolism	1/31	0.28324583491784594	0.4408013305908977	0	0	3.10094696969697	3.911658805304529	OMD
Regulation of Endogenous Retroelements by KRAB-ZFP Proteins	1/31	0.28324583491784594	0.4408013305908977	0	0	3.10094696969697	3.911658805304529	ZNF778
Kinesins	1/31	0.28324583491784594	0.4408013305908977	0	0	3.10094696969697	3.911658805304529	TUBAL3
Bile Acid and Bile Salt Metabolism	1/32	0.29091187472888475	0.4443991215183577	0	0	3.0007331378299122	3.7051099118342568	OSBPL3
Circadian Clock	1/32	0.29091187472888475	0.4443991215183577	0	0	3.0007331378299122	3.7051099118342568	HELZ2
Regulation of PTEN Stability and Activity	1/32	0.29091187472888475	0.4443991215183577	0	0	3.0007331378299122	3.7051099118342568	CSNK2A2
G2 M DNA Damage Checkpoint	1/32	0.29091187472888475	0.4443991215183577	0	0	3.0007331378299122	3.7051099118342568	TOPBP1
TNF Signaling	1/32	0.29091187472888475	0.4443991215183577	0	0	3.0007331378299122	3.7051099118342568	TNFAIP3
Intraflagellar Transport	1/32	0.29091187472888475	0.4443991215183577	0	0	3.0007331378299122	3.7051099118342568	DYNC2I1
Signaling by GPCR	6/420	0.29263834401057787	0.44566940463996263	0	0	1.3551148402406983	1.6651891732439938	TIAM2;NET1;ARHGEF25;TAAR2;TAS1R2;RGS12
Generic Transcription Pathway	9/675	0.2952655317392514	0.4482994963602049	0	0	1.2658462033462032	1.5441807449045704	IL2RA;CSNK2A2;ERBB2;ZNF74;TNFRSF10C;ZNF778;ZNF613;TOPBP1;ZNF169
Neurexins and Neuroligins	1/33	0.29849638066902523	0.4504581744641653	0	0	2.9067826704545454	3.51429289815426	NRXN3
Signaling by NOTCH3	1/33	0.29849638066902523	0.4504581744641653	0	0	2.9067826704545454	3.51429289815426	EGF
Mitotic Prometaphase	2/103	0.30110951690103455	0.4527889012916547	0	0	1.8446393210749645	2.214085965903307	TUBAL3;CSNK2A2
Translation	3/180	0.3018592675277698	0.4527889012916547	0	0	1.5805571790375998	1.8931824933331098	EPRS1;LARS1;MRPL21
Base Excision Repair	1/34	0.3060002150046302	0.4548898718576294	0	0	2.818526170798898	3.3376126542589644	POLE
Cytochrome P450 - Arranged by Substrate Type	1/34	0.3060002150046302	0.4548898718576294	0	0	2.818526170798898	3.3376126542589644	CYP27B1
HCMV Late Events	1/34	0.3060002150046302	0.4548898718576294	0	0	2.818526170798898	3.3376126542589644	CHMP1A
Signaling by Interleukins	4/263	0.309164062108971	0.4577280557810812	0	0	1.4412033833999152	1.6918044361687985	STAT2;IL2RA;NLRC5;IL17RA
Adherens Junctions Interactions	1/35	0.31342423096656363	0.4577280557810812	0	0	2.735461229946524	3.173675651334016	CDH15
Complex I Biogenesis	1/35	0.31342423096656363	0.4577280557810812	0	0	2.735461229946524	3.173675651334016	ACAD9
RHOC GTPase Cycle	1/35	0.31342423096656363	0.4577280557810812	0	0	2.735461229946524	3.173675651334016	ARHGEF25
Sensory Processing of Sound by Inner Hair Cells of the Cochlea	1/35	0.31342423096656363	0.4577280557810812	0	0	2.735461229946524	3.173675651334016	MYO1C
The Role of GTSE1 in G2 M Progression After G2 Checkpoint	1/35	0.31342423096656363	0.4577280557810812	0	0	2.735461229946524	3.173675651334016	TUBAL3
Transcriptional Regulation by RUNX1	2/107	0.31684896066143087	0.4613765567526099	0	0	1.7739319727891156	2.038833382303861	IL2RA;CSNK2A2
Signaling by EGFR	1/36	0.3207692727868707	0.4630274541082519	0	0	2.657142857142857	3.021259620898141	EGF
Gap-filling DNA Repair Synthesis and Ligation in TC-NER	1/36	0.3207692727868707	0.4630274541082519	0	0	2.657142857142857	3.021259620898141	POLE
Mitotic Anaphase	2/108	0.32077203146053596	0.4630274541082519	0	0	1.757088948787062	1.99785334249657	ANKLE2;TUBAL3
Mitotic Metaphase and Anaphase	2/109	0.32468969792633934	0.46674861600288925	0	0	1.7405607476635514	1.9579312481525142	ANKLE2;TUBAL3
NoRC Negatively Regulates rRNA Expression	1/37	0.32803617590564504	0.46674861600288925	0	0	2.583175505050505	2.879288489044239	TAF1B
RNA Polymerase I Promoter Clearance	1/37	0.32803617590564504	0.46674861600288925	0	0	2.583175505050505	2.879288489044239	TAF1B
RNA Polymerase I Transcription	1/37	0.32803617590564504	0.46674861600288925	0	0	2.583175505050505	2.879288489044239	TAF1B
Dual Incision in TC-NER	1/37	0.32803617590564504	0.46674861600288925	0	0	2.583175505050505	2.879288489044239	POLE
tRNA Processing in the Nucleus	1/38	0.3352257668225801	0.4729247361972943	0	0	2.513206388206388	2.7468115441008094	TSEN2
Negative Epigenetic Regulation of rRNA Expression	1/38	0.3352257668225801	0.4729247361972943	0	0	2.513206388206388	2.7468115441008094	TAF1B
Processing of DNA Double-Strand Break Ends	1/38	0.3352257668225801	0.4729247361972943	0	0	2.513206388206388	2.7468115441008094	TOPBP1
Transport to the Golgi and Subsequent Modification	2/112	0.33640700376662797	0.4732505307225444	0	0	1.6927792207792207	1.844170444275803	TUBAL3;SPTB
Hedgehog 'On' State	1/39	0.34233886343384956	0.47888975839903675	0	0	2.44691985645933	2.6229860262788978	GLI1
UCH Proteinases	1/39	0.34233886343384956	0.47888975839903675	0	0	2.44691985645933	2.6229860262788978	MBD6
Biological Oxidations	2/115	0.34806422047733737	0.48465009748557375	0	0	1.6475347661188369	1.7387559235147847	CYP27B1;UGT3A1
Transport of Small Molecules	6/450	0.3489876576639406	0.48465009748557375	0	0	1.2611822348664454	1.3276701508317077	SLC36A1;CUBN;CLCA3P;APOF;ESYT2;ESYT1
Sensory Processing of Sound	1/40	0.34937627509502206	0.48465009748557375	0	0	2.384032634032634	2.5070625106111604	MYO1C
Deubiquitination	2/117	0.35579837365720424	0.4915698717392192	0	0	1.6186832298136646	1.6727328024680472	MBD6;TNFAIP3
Interleukin-17 Signaling	1/41	0.3563388026061408	0.4915698717392192	0	0	2.3242897727272727	2.398372576508212	IL17RA
Regulation of Actin Dynamics for Phagocytic Cup Formation	1/42	0.36322723818962793	0.49831174826015073	0	0	2.2674611973392462	2.296318359828501	MYO1C
HCMV Early Events	1/42	0.36322723818962793	0.49831174826015073	0	0	2.2674611973392462	2.296318359828501	TUBAL3
Extracellular Matrix Organization	3/203	0.36895635092212914	0.4994067703464137	0	0	1.3968103448275861	1.3927273733774896	MUSK;MMP15;COL9A2
Transcriptional Regulation by TP53	3/203	0.36895635092212914	0.4994067703464137	0	0	1.3968103448275861	1.3927273733774896	CSNK2A2;TNFRSF10C;TOPBP1
Parasite Infection	1/43	0.3700423659795716	0.4994067703464137	0	0	2.2133387445887447	2.2003636598496463	MYO1C
FCGR3A-mediated Phagocytosis	1/43	0.3700423659795716	0.4994067703464137	0	0	2.2133387445887447	2.2003636598496463	MYO1C
Leishmania Phagocytosis	1/43	0.3700423659795716	0.4994067703464137	0	0	2.2133387445887447	2.2003636598496463	MYO1C
Mitochondrial Biogenesis	1/43	0.3700423659795716	0.4994067703464137	0	0	2.2133387445887447	2.2003636598496463	HELZ2
Assembly of Collagen Fibrils and Other Multimeric Structures	1/44	0.37678496166068487	0.5017083179332114	0	0	2.1617336152219875	2.110026347394458	COL9A2
Post NMDA Receptor Activation Events	1/44	0.37678496166068487	0.5017083179332114	0	0	2.1617336152219875	2.110026347394458	TUBAL3
Collagen Biosynthesis and Modifying Enzymes	1/44	0.37678496166068487	0.5017083179332114	0	0	2.1617336152219875	2.110026347394458	COL9A2
Signaling by PDGF	1/44	0.37678496166068487	0.5017083179332114	0	0	2.1617336152219875	2.110026347394458	COL9A2
Transcription-Coupled Nucleotide Excision Repair (TC-NER)	1/44	0.37678496166068487	0.5017083179332114	0	0	2.1617336152219875	2.110026347394458	POLE
Extra-nuclear Estrogen Signaling	1/46	0.39005561921034565	0.5167689379292376	0	0	2.0654040404040406	1.9445075494945954	EGF
SARS-CoV-2-host Interactions	2/126	0.3901709250228782	0.5167689379292376	0	0	1.50036866359447	1.412102525121773	STAT2;IL17RA
Costimulation by the CD28 Family	1/47	0.3965851921105557	0.5211066640397276	0	0	2.020380434782609	1.8685779399655713	PDCD1
Recruitment of NuMA to Mitotic Centrosomes	1/47	0.3965851921105557	0.5211066640397276	0	0	2.020380434782609	1.8685779399655713	TUBAL3
Global Genome Nucleotide Excision Repair (GG-NER)	1/47	0.3965851921105557	0.5211066640397276	0	0	2.020380434782609	1.8685779399655713	POLE
RNA Polymerase II Transcription	9/745	0.40067867188711076	0.5250999436836347	0	0	1.1403581133540373	1.0429663873346566	IL2RA;CSNK2A2;ERBB2;ZNF74;TNFRSF10C;ZNF778;ZNF613;TOPBP1;ZNF169
Antimicrobial Peptides	1/48	0.403045255152655	0.5254359609058172	0	0	1.9772727272727273	1.79676043654115	GNLY
Regulation of Endogenous Retroelements	1/48	0.403045255152655	0.5254359609058172	0	0	1.9772727272727273	1.79676043654115	ZNF778
RAB GEFs Exchange GTP for GDP on RABs	1/49	0.4094365442403923	0.5309880183117587	0	0	1.9359611742424243	1.7287617290697472	DENND1C
RAC3 GTPase Cycle	1/49	0.4094365442403923	0.5309880183117587	0	0	1.9359611742424243	1.7287617290697472	ESYT1
Mitochondrial Translation Initiation	1/50	0.41575978739341335	0.5361321966453847	0	0	1.8963358070500929	1.6643146071157653	MRPL21
Mitochondrial Protein Degradation	1/50	0.41575978739341335	0.5361321966453847	0	0	1.8963358070500929	1.6643146071157653	LONP1
Neddylation	2/134	0.4200319619600981	0.5361321966453847	0	0	1.4087445887445889	1.2219795292364717	KLHL22;NFE2L2
Mitochondrial Translation Elongation	1/51	0.42201570498994134	0.5361321966453847	0	0	1.8582954545454546	1.6031751819454705	MRPL21
Mitochondrial Translation Termination	1/51	0.42201570498994134	0.5361321966453847	0	0	1.8582954545454546	1.6031751819454705	MRPL21
Activation of NMDA Receptors and Postsynaptic Events	1/51	0.42201570498994134	0.5361321966453847	0	0	1.8582954545454546	1.6031751819454705	TUBAL3
Protein-protein Interactions at Synapses	1/51	0.42201570498994134	0.5361321966453847	0	0	1.8582954545454546	1.6031751819454705	NRXN3
Unfolded Protein Response (UPR)	1/51	0.42201570498994134	0.5361321966453847	0	0	1.8582954545454546	1.6031751819454705	ATF6
Phase I - Functionalization of Compounds	1/52	0.42820500984306026	0.5412337434056954	0	0	1.82174688057041	1.5451204520321853	CYP27B1
Cell-cell Junction Organization	1/52	0.42820500984306026	0.5412337434056954	0	0	1.82174688057041	1.5451204520321853	CDH15
COPI-dependent Golgi-to-ER Retrograde Traffic	1/53	0.43432840723963984	0.5462008757710622	0	0	1.786604020979021	1.4899461634447337	TUBAL3
Integrin Cell Surface Interactions	1/53	0.43432840723963984	0.5462008757710622	0	0	1.786604020979021	1.4899461634447337	COL9A2
Mitochondrial Translation	1/54	0.4403865951408935	0.5507345434469201	0	0	1.7527873070325901	1.437464923844189	MRPL21
Signaling by Receptor Tyrosine Kinases	4/319	0.4441564932535226	0.5507345434469201	0	0	1.1808789797229104	0.9583757741972231	ERBB3;EGF;ERBB2;COL9A2
Mitotic Prophase	1/55	0.44638026387637736	0.5507345434469201	0	0	1.720223063973064	1.3875045385484945	NCAPG2
MyD88 Cascade Initiated on Plasma Membrane	1/55	0.44638026387637736	0.5507345434469201	0	0	1.720223063973064	1.3875045385484945	NLRC5
Gene Silencing by RNA	1/55	0.44638026387637736	0.5507345434469201	0	0	1.720223063973064	1.3875045385484945	DROSHA
Toll Like Receptor 10 (TLR10) Cascade	1/55	0.44638026387637736	0.5507345434469201	0	0	1.720223063973064	1.3875045385484945	NLRC5
Toll Like Receptor 5 (TLR5) Cascade	1/55	0.44638026387637736	0.5507345434469201	0	0	1.720223063973064	1.3875045385484945	NLRC5
Post-translational Modification Synthesis of GPI-anchored Proteins	1/56	0.4523100969272898	0.5507345434469201	0	0	1.6888429752066116	1.3399065331446696	PIGM
DNA Replication Pre-Initiation	1/56	0.4523100969272898	0.5507345434469201	0	0	1.6888429752066116	1.3399065331446696	POLE
Fcgamma Receptor (FCGR) Dependent Phagocytosis	1/56	0.4523100969272898	0.5507345434469201	0	0	1.6888429752066116	1.3399065331446696	MYO1C
Hedgehog 'Off' State	1/56	0.4523100969272898	0.5507345434469201	0	0	1.6888429752066116	1.3399065331446696	GLI1
Interleukin-1 Signaling	1/56	0.4523100969272898	0.5507345434469201	0	0	1.6888429752066116	1.3399065331446696	NLRC5
Metabolism of Nucleotides	1/56	0.4523100969272898	0.5507345434469201	0	0	1.6888429752066116	1.3399065331446696	DHODH
TRAF6 Mediated Induction of NFkB and MAP Kinases Upon TLR7 8 or 9 Activation	1/58	0.4639809527339918	0.562195898933158	0	0	1.6293859649122806	1.2512246729415695	NLRC5
Visual Phototransduction	1/58	0.4639809527339918	0.562195898933158	0	0	1.6293859649122806	1.2512246729415695	CNGB1
MyD88 Dependent Cascade Initiated on Endosome	1/59	0.46972330639979776	0.562312996603604	0	0	1.6011951410658307	1.2098814101718833	NLRC5
Phase II - Conjugation of Compounds	1/59	0.46972330639979776	0.562312996603604	0	0	1.6011951410658307	1.2098814101718833	UGT3A1
EML4 and NUDC in Mitotic Spindle Formation	1/59	0.46972330639979776	0.562312996603604	0	0	1.6011951410658307	1.2098814101718833	TUBAL3
Toll Like Receptor 3 (TLR3) Cascade	1/59	0.46972330639979776	0.562312996603604	0	0	1.6011951410658307	1.2098814101718833	NLRC5
Transcriptional Regulation of White Adipocyte Differentiation	1/59	0.46972330639979776	0.562312996603604	0	0	1.6011951410658307	1.2098814101718833	HELZ2
Drug ADME	1/60	0.47540448605276725	0.5650392220865825	0	0	1.573959938366718	1.1703797494783779	UGT3A1
Resolution of Sister Chromatid Cohesion	1/60	0.47540448605276725	0.5650392220865825	0	0	1.573959938366718	1.1703797494783779	TUBAL3
Toll Like Receptor 7 8 (TLR7 8) Cascade	1/60	0.47540448605276725	0.5650392220865825	0	0	1.573959938366718	1.1703797494783779	NLRC5
Nucleotide Excision Repair	1/61	0.4810251398422281	0.5676552598138143	0	0	1.5476325757575757	1.1326128382268834	POLE
Cargo Recognition for Clathrin-Mediated Endocytosis	1/61	0.4810251398422281	0.5676552598138143	0	0	1.5476325757575757	1.1326128382268834	EGF
Synthesis of DNA	1/61	0.4810251398422281	0.5676552598138143	0	0	1.5476325757575757	1.1326128382268834	POLE
Collagen Formation	1/62	0.4865859088304282	0.5728600061407878	0	0	1.5221684053651268	1.0964815404050219	COL9A2
MyD88-independent TLR4 Cascade	1/63	0.4920874276260908	0.5748726247064739	0	0	1.497525659824047	1.0618937679268312	NLRC5
TRIF (TICAM1)-mediated TLR4 Signaling	1/63	0.4920874276260908	0.5748726247064739	0	0	1.497525659824047	1.0618937679268312	NLRC5
Transport of Inorganic Cations Anions and Amino Acids Oligopeptides	1/63	0.4920874276260908	0.5748726247064739	0	0	1.497525659824047	1.0618937679268312	SLC36A1
MyD88 MAL(TIRAP) Cascade Initiated on Plasma Membrane	1/64	0.4975303237921491	0.5748726247064739	0	0	1.4736652236652237	1.0287638828250336	NLRC5
Toll Like Receptor 2 (TLR2) Cascade	1/64	0.4975303237921491	0.5748726247064739	0	0	1.4736652236652237	1.0287638828250336	NLRC5
Toll Like Receptor 9 (TLR9) Cascade	1/64	0.4975303237921491	0.5748726247064739	0	0	1.4736652236652237	1.0287638828250336	NLRC5
Toll Like Receptor TLR1 TLR2 Cascade	1/64	0.4975303237921491	0.5748726247064739	0	0	1.4736652236652237	1.0287638828250336	NLRC5
Toll Like Receptor TLR6 TLR2 Cascade	1/64	0.4975303237921491	0.5748726247064739	0	0	1.4736652236652237	1.0287638828250336	NLRC5
PTEN Regulation	1/66	0.5082427268780321	0.5845378244463278	0	0	1.428146853146853	0.9665642728542152	CSNK2A2
Stimuli-sensing Channels	1/66	0.5082427268780321	0.5845378244463278	0	0	1.428146853146853	0.9665642728542152	CLCA3P
Cell Junction Organization	1/67	0.5135134564182958	0.5858684592329305	0	0	1.40642217630854	0.9373509084592742	CDH15
RSV-host Interactions	1/67	0.5135134564182958	0.5858684592329305	0	0	1.40642217630854	0.9373509084592742	STAT2
Rab Regulation of Trafficking	1/67	0.5135134564182958	0.5858684592329305	0	0	1.40642217630854	0.9373509084592742	DENND1C
Diseases of Signal Transduction by Growth Factor Receptors and Second Messengers	3/255	0.5141054551903426	0.5858684592329305	0	0	1.1050218938149972	0.7352007566012118	ERBB3;EGF;ERBB2
G2 M Checkpoints	1/68	0.5187280090328177	0.5897866404071763	0	0	1.3853459972862958	0.9093073109545374	TOPBP1
RHO GTPases Activate Formins	1/70	0.5289909587868351	0.6000854156625145	0	0	1.345026350461133	0.8564911767119918	TUBAL3
Glycerophospholipid Biosynthesis	1/71	0.5340405280069154	0.6029341755603851	0	0	1.3257305194805196	0.8316089436305272	CSNK2A2
Innate Immune System	7/644	0.5348310126390831	0.6029341755603851	0	0	1.0191338073691014	0.6377784679322216	TMEM63A;PTPRN2;MYO1C;GNLY;NLRC5;TNFAIP3;CD33
Adaptive Immune System	5/454	0.5351343485897394	0.6029341755603851	0	0	1.0329155228673539	0.6458174621621238	TUBAL3;KLHL22;PDCD1;CD33;PJA2
DNA Replication	1/72	0.5390362644294762	0.605959502676928	0	0	1.3069782330345712	0.807676513829761	POLE
Antigen Processing Ubiquitination & Proteasome Degradation	2/169	0.540895325158325	0.6066798917316348	0	0	1.111103507271172	0.6828058859402458	KLHL22;PJA2
Interleukin-1 Family Signaling	1/73	0.5439787387574943	0.6087672177555777	0	0	1.2887468434343434	0.7846472214580146	NLRC5
G1 S Transition	1/74	0.5488685156756684	0.6128621542746252	0	0	1.2710149439601495	0.762477243490837	POLE
Adipogenesis	1/75	0.5537061538823778	0.6155037156996074	0	0	1.253762285012285	0.7411253925915906	HELZ2
Signaling by Hedgehog	1/75	0.5537061538823778	0.6155037156996074	0	0	1.253762285012285	0.7411253925915906	GLI1
Golgi-to-ER Retrograde Transport	1/76	0.5584922062119992	0.6180647082079458	0	0	1.236969696969697	0.7205529273262782	TUBAL3
Metabolism of Water-Soluble Vitamins and Cofactors	1/76	0.5584922062119992	0.6180647082079458	0	0	1.236969696969697	0.7205529273262782	CUBN
MHC Class II Antigen Presentation	1/78	0.5679117354436829	0.6270954417981244	0	0	1.2046930342384887	0.6816023896230663	TUBAL3
Cardiac Conduction	1/80	0.5771314102976849	0.6358660228501042	0	0	1.1740506329113924	0.645358363708551	SCN9A
Platelet Degranulation	1/81	0.5816676236146597	0.6394491756293611	0	0	1.1593039772727274	0.6281759177333984	EGF
Respiratory Electron Transport	1/82	0.5861554476319515	0.6415503580674986	0	0	1.1449214365881033	0.6115829764084088	ACAD9
Response to Elevated Platelet Cytosolic Ca2+	1/82	0.5861554476319515	0.6415503580674986	0	0	1.1449214365881033	0.6115829764084088	EGF
SARS-CoV-2 Infection	2/185	0.590100469573082	0.644451828612708	0	0	1.0129586260733803	0.5342976580733092	STAT2;IL17RA
S Phase	1/84	0.5949879756271985	0.6469519909658185	0	0	1.1171960569550932	0.5800639258751846	POLE
Toll Like Receptor 4 (TLR4) Cascade	1/84	0.5949879756271985	0.6469519909658185	0	0	1.1171960569550932	0.5800639258751846	NLRC5
Glycosaminoglycan Metabolism	1/85	0.5993336899923375	0.6502574675733858	0	0	1.1038284632034632	0.5650903643172558	OMD
Separation of Sister Chromatids	1/86	0.6036330359193736	0.6534983736692348	0	0	1.0907754010695188	0.550611229891784	TUBAL3
Factors Involved in Megakaryocyte Development and Platelet Production	1/87	0.6078865054518172	0.6552542850974133	0	0	1.0780258985200846	0.5366058070185369	TUBAL3
G Alpha (S) Signalling Events	1/87	0.6078865054518172	0.6552542850974133	0	0	1.0780258985200846	0.5366058070185369	TAAR2
Mitotic G1 Phase and G1 S Transition	1/88	0.6120945853955272	0.6583652343995087	0	0	1.065569487983281	0.5230544505117124	POLE
Neutrophil Degranulation	3/300	0.6242754879004921	0.668767175342577	0	0	0.9349820039475212	0.4405294130696983	TMEM63A;PTPRN2;CD33
Cell-Cell Communication	1/91	0.6244512781813218	0.668767175342577	0	0	1.0298611111111111	0.4849430286036901	CDH15
Fatty Acid Metabolism	1/94	0.6364165011465754	0.6801189218261686	0	0	0.9964565004887586	0.4503007392557668	ACSF3
TCF Dependent Signaling in Response to WNT	1/95	0.6403200584681752	0.6811095670356205	0	0	0.9857954545454546	0.43945493263562163	CSNK2A2
G Alpha (I) Signalling Events	2/203	0.6406737763993885	0.6811095670356205	0	0	0.9212224591329069	0.41016037176757936	TAS1R2;RGS12
Mitotic G2-G2 M Phases	1/96	0.6441819399071833	0.6811095670356205	0	0	0.9753588516746412	0.4289375391232034	TUBAL3
G2 M Transition	1/96	0.6441819399071833	0.6811095670356205	0	0	0.9753588516746412	0.4289375391232034	TUBAL3
Immunoregulatory Interactions Between a Lymphoid and a non-Lymphoid Cell	1/96	0.6441819399071833	0.6811095670356205	0	0	0.9753588516746412	0.4289375391232034	CD33
Cell Surface Interactions at the Vascular Wall	1/97	0.6480025879835216	0.6836976457961733	0	0	0.965139678030303	0.41873606901931765	GLG1
Class I MHC Mediated Antigen Processing & Presentation	2/211	0.661534241194486	0.6935189139119519	0	0	0.8855228981544772	0.36589233556002926	KLHL22;PJA2
Parasitic Infection Pathways	1/101	0.6628815321728696	0.6935189139119519	0	0	0.9263068181818181	0.3808593751154418	MYO1C
Toll-like Receptor Cascades	1/101	0.6628815321728696	0.6935189139119519	0	0	0.9263068181818181	0.3808593751154418	NLRC5
Leishmania Infection	1/101	0.6628815321728696	0.6935189139119519	0	0	0.9263068181818181	0.3808593751154418	MYO1C
ESR-mediated Signaling	1/103	0.6700847685614746	0.6995853558566338	0	0	0.9080325311942959	0.3635317812560252	EGF
Intra-Golgi and Retrograde Golgi-to-ER Traffic	1/111	0.697399100196316	0.726578978865618	0	0	0.8415805785123966	0.3033034818143504	TUBAL3
Phospholipid Metabolism	1/112	0.7006512777642532	0.7284432908697245	0	0	0.833947583947584	0.2966726663085285	CSNK2A2
Signaling by NOTCH	1/113	0.703868697916048	0.7302637740878999	0	0	0.8264508928571429	0.2902193458499436	EGF
Metabolism of Vitamins and Cofactors	1/116	0.7133160885602718	0.7385268442890133	0	0	0.8047430830039526	0.2718668666159934	CUBN
Ion Channel Transport	1/119	0.7224637286821012	0.7464459271445777	0	0	0.7841390600924499	0.25491424798920265	CLCA3P
Neurotransmitter Receptors and Postsynaptic Signal Transmission	1/122	0.7313210764195458	0.7540329110909603	0	0	0.7645567242674681	0.23923185310974002	TUBAL3
Muscle Contraction	1/125	0.7398972932131691	0.7612992810333847	0	0	0.7459219208211144	0.22470442507131716	SCN9A
Neuronal System	2/248	0.7456314145875718	0.7656174112672386	0	0	0.7506155632984901	0.22032359492939513	TUBAL3;NRXN3
Cell Cycle Checkpoints	1/130	0.7535902284267603	0.7721973945607544	0	0	0.7167899929527837	0.20278456414653592	TOPBP1
G Alpha (Q) Signalling Events	1/133	0.7614593940229232	0.7786586821836051	0	0	0.7003701790633609	0.1908637828370657	ARHGEF25
Hemostasis	3/377	0.7704121990819277	0.7861993343090163	0	0	0.738936013276784	0.19273637286127815	TUBAL3;EGF;GLG1
Signaling by Nuclear Receptors	1/143	0.7859287671430392	0.8003937137775735	0	0	0.6506482074263764	0.15673407262281683	EGF
RHO GTPase Effectors	1/146	0.7927705328111165	0.8057137251835429	0	0	0.6370689655172413	0.14794108858022176	TUBAL3
Signaling by WNT	1/147	0.7950024506219868	0.8063364977795303	0	0	0.6326665628891657	0.14514008793768068	CSNK2A2
SLC-mediated Transmembrane Transport	1/148	0.7972104641136398	0.806932542944294	0	0	0.6283240568954854	0.14240120573942053	SLC36A1
GPCR Ligand Binding	2/280	0.8033581946394021	0.811505843672256	0	0	0.6628982528263104	0.14514461778471816	TAAR2;TAS1R2
Platelet Activation, Signaling and Aggregation	1/155	0.8120182887149148	0.8185933355871003	0	0	0.5995056080283353	0.12483650118098104	EGF
Transmission Across Chemical Synapses	1/166	0.8331446699794229	0.8381940316156619	0	0	0.5591597796143251	0.1020734873991961	TUBAL3
Metabolism of Carbohydrates	1/171	0.8419500905724854	0.8453450506151164	0	0	0.5425467914438503	0.09333678842758861	OMD
Class A 1 (Rhodopsin-like Receptors)	1/214	0.9009162000781666	0.9027289087302353	0	0	0.4318715322236449	0.04506278570340553	TAAR2
Metabolism of RNA	2/396	0.9271616172521163	0.9271616172521163	0	0	0.46436548223350255	0.0351187467432437	EPRS1;TSEN2
